Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer-Reference-Cited by-同舟云学术

Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer

Published:2020 Issue:4 Volume:34 Page:1921-1929
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

KUROSAKI TAKASHI,KAWAKAMI HISATO,MITANI SEIICHIRO,KAWABATA RYOHEI,TAKAHAMA TAKAYUKI,NONAGASE YOSHIKANE,FUMITA SOICHI,OZAKI TOMOHIRO,CHIBA YASUTAKA,TAMURA TAKAO,NAKAGAWA KAZUHIKO

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma;Frontiers in Oncology;2024-07-23

2. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer;The American Surgeon™;2024-04-21

3. The Association of Inflammatory Related Markers with the Prognosis in Elderly Patients with Colorectal Cancer;Cancer Management and Research;2024-01

4. The Glasgow prognosis score is unsuitable for stroke prediction in infectious endocarditis;Revista da Associação Médica Brasileira;2024

5. The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery;Anticancer Research;2023-11